We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Legendary Inv. | LSE:LEG | London | Ordinary Share | GB0001514032 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.085 | 0.08 | 0.09 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
13/10/2017 18:34 | I agreeBut I don't like this one bit feathering his own best but equally he will have his attention on ibs for his own personal gain rather than helping VS | turbotrader2 | |
13/10/2017 18:33 | Frankly if VS IPO’s for £500m in 2018/19 then he can have the remaining LEG stake in IBSCorp for free for all I care. | lendmeafiver | |
13/10/2017 18:26 | I wouldn’t get too wound up by IBSCorp, the value here is all about VS, the value current and future in the other investments are not what any of us are invested here for if we are honest, none of us are here because of IBSCorp. | lendmeafiver | |
13/10/2017 18:19 | If there is any kind of spike I will sell 13m shares straight into itI do not like this one bitHe's feathered his own nest imho | turbotrader2 | |
13/10/2017 18:17 | It was a 20k punt you're not saying it's him?Listen, why wasn't this put out early Friday pm RNS are always sinister | turbotrader2 | |
13/10/2017 18:15 | Also, turbo - who was the 14.3m buyer the other day? | professor pettigrew | |
13/10/2017 18:15 | PPYou're wrong and I hate falling out or disagreeing but why couldn't he have done 25/25?He's a greedy MF | turbotrader2 | |
13/10/2017 18:06 | I'm sorry but I think it's a conflict of interest!Why didn't he make US shareholders a bigger holder? | turbotrader2 | |
13/10/2017 18:05 | Why isn't the supposed CEO of IBS listed on their directors?"An opportunity to hear the CEO of Legendary Investments, Zafar Karim, and the CEO of the banking platform IBS, Tim Munro-Keene, talk about their vision for the future of both companies"Only one director according to the filing in NZ and that's Andrew Mackay. https://app.companie | soupdragon55 | |
13/10/2017 17:58 | Well, I did think that IBS would present a "unique model". I didn't think in a million years that Zaf would take a personal 37% stake. This is huge news. Wait until Zaf and the IBS big cheese explain it all on the 25th. And people honestly doubt that LEG are undervalued? Anyone with any financial sense will be piling in here big time on Monday morning. | professor pettigrew | |
13/10/2017 17:57 | Shame it wasn't 39% - then leg/zaf would be in control | gottopickapocketortwo | |
13/10/2017 17:43 | although that was a cheeky RNS OUT OF HOUR we would have gone ballistic if it came in the day...but we could still have a good bounce for Monday GLA REGARDS | livup967 | |
13/10/2017 17:37 | THAT'S GOOD NEWS he must know that it's in the bag...AND WILL HAVE ALL THE FUNDING THAT LEG NEED'S IN THE FUTURE... and he will have a lot of voting right's to make sure it happens good move REGARDS | livup967 | |
13/10/2017 17:30 | Unique business model indeed. | soupdragon55 | |
13/10/2017 17:28 | Can't wait for LEG to rns that Zaf has put a tenner on the horses. Pretty much the same as today's rns. | soupdragon55 | |
13/10/2017 17:06 | Is there no end to his talents ? | chinese investor | |
13/10/2017 17:01 | Eyup, RNS at 16.53 friday PM.... Stake in IBS Corporation Limited ("IBS") Further to its announcement of 7 July 2017 in which Legendary announced that it had taken a 12% stake in IBS for nominal consideration, the Company is pleased to announce that Zafarullah Karim, Executive Chairman of Legendary, has taken a 37% stake in IBS for nominal consideration on the same terms that Legendary acquired its stake. As part of his role as Legendary's Executive Chaiman, Zafar Karim will help develop the IBS business proposition as he and the Legendary board have done so with other investee companies. IBS has commenced the process of obtaining the necessary authorities from the New Zealand regulators to be able to conduct a range of financial services including investment banking, asset management, debt funding and insurance services aimed at corporate and high net worth clients. Further announcements on progress at IBS will be made in due course. | philmiboots | |
13/10/2017 15:50 | Provident are down 70% this year because one of their customers, a small, ugly Sutton man, can't repay the loan. | liberace pickles | |
13/10/2017 15:23 | Yes, that's superb news Mickluv1. Will give Virtualstock broader coverage, and may result in government contracts for them going forward. Every little helps as they say. | professor pettigrew | |
13/10/2017 13:32 | https://twitter.com/ | mickluv1 | |
13/10/2017 13:07 | This Is Not A Reversal ! | chinese investor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions